| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Tamer I Khayal last filed a Form 4 in March 2025, as Chief Commercial Officer at TMDX. From May 2019 to March 2025, the filings on record show 0 open-market purchases and 43 sales. Tamer I Khayal's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Tamer I Khayal's trades have earned a middling insider score of 53/100 across 47 rated trades. Over a 12-month horizon, 46.8% of those trades were profitable, with an average 12-month return of -14.3%.
At the last filing, the largest reported position was 36,042 shares of TMDX. The TMDX filings lean toward selling, a net 402,101 shares.
Shares as reported in the last Form 4 for each company; the most recent is from March 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2024 | TMDX Transmedics Group, Inc. | Chief Commercial Officer | Sale+OE10b5-1 | 5,839 | $130.07 | $759,478.73 | -37.4% | +11.9% | -29.6% | |
| May 1, 2024 | TMDX Transmedics Group, Inc. | Chief Commercial Officer | Sale+OE10b5-1 | 75,818 | $110.02 | $8,341,610.68 | - | +17.7% | -23.1% | |
| Apr 9, 2024 | TMDX Transmedics Group, Inc. | Chief Commercial Officer | Sale+OE10b5-1 | 19,900 | $90.35 | $1,798,002.28 | -44.1% | +60.0% | -19.1% | |
| Apr 4, 2024 | TMDX Transmedics Group, Inc. | Chief Commercial Officer | Sale+OE10b5-1 | 10,000 | $80.21 | $802,084.10 | -28.4% | +93.7% | -12.3% | |
| Mar 8, 2024 | TMDX Transmedics Group, Inc. | Chief Commercial Officer | Sale+OE10b5-1 | 1,417 | $87.80 | $124,412.71 | -5.3% | +58.8% | -19.5% | |
| Mar 1, 2024 | TMDX Transmedics Group, Inc. | Chief Commercial Officer | Sale+OE10b5-1 | 10,000 | $82.99 | $829,891.92 | -27.4% | +64.9% | -7.7% | |
| Feb 20, 2024 | TMDX Transmedics Group, Inc. | Chief Commercial Officer | Sale+OE10b5-1 | 3,108 | $90.00 | $279,720.00 | -17.8% | +56.4% | -10.4% | |
| Feb 15, 2024 | TMDX Transmedics Group, Inc. | Chief Commercial Officer | Sale+OE10b5-1 | 3,826 | $90.02 | $344,431.50 | -21.0% | +52.2% | -19.3% | |
| Feb 7, 2024 | TMDX Transmedics Group, Inc. | Chief Commercial Officer | Sale+OE10b5-1 | 736 | $90.09 | $66,306.24 | -4.9% | +44.4% | -16.6% | |
| Jan 23, 2024 | TMDX Transmedics Group, Inc. | Chief Commercial Officer | Sale+OE10b5-1 | 2,330 | $90.09 | $209,909.70 | -13.9% | +1.9% | -27.0% |